Corcept Therapeutics Inc’s recently made public that its Officer Maduck Sean acquired Company’s shares for reported $10.05 million on Mar 31 ’25. In the deal valued at $100.54 per share,100,000 shares were bought.
Then, Lyon Joseph Douglas bought 200,000 shares, generating $20,093,500 in total proceeds.
Before that, Lyon Joseph Douglas sold 421 shares. Corcept Therapeutics Inc shares valued at $25,504 were divested by the insider at a price of $60.58 per share. As a result of the transaction, Lyon Joseph Douglas now holds 9,009 shares, worth roughly $1.03 million.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Monday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock jump 109.08% to $114.22. Over the last five days, the stock has gained 92.06%. Corcept Therapeutics Inc shares have risen nearly 126.67% since the year began. Nevertheless, the stocks have risen 351.11% over the past one year. While a 52-week high of $75.00 was reached on 03/31/25, a 52-week low of $20.84 was recorded on 01/13/25. SMA at 50 days reached $62.71, while 200 days put it at $48.23.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 95.42, which if violated will result in even more drops to 76.63. On the upside, there is a resistance level at 125.17. A further resistance level may holdings at 136.13. The Relative Strength Index (RSI) on the 14-day chart is 86.54, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 14.11, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 4.89%. Stochastics %K at 50.81% indicates the stock is a holding.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2025-03-14, growing by 0.94 million shares to a total of 16.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 15.39 million shares. There was a rise of 5.74%, which implies that there is a positive sentiment for the stock.
